• Nenhum resultado encontrado

ROLE OF GALECTIN-3 IN CARCINOGENESIS AND METASTASIS OF CANINE MALIGNANT MAMMARY TUMOURS

N/A
N/A
Protected

Academic year: 2019

Share "ROLE OF GALECTIN-3 IN CARCINOGENESIS AND METASTASIS OF CANINE MALIGNANT MAMMARY TUMOURS"

Copied!
197
0
0

Texto

Loading

Imagem

Table I. Clinicopathological features of the malignant canine mammary tumors
Fig. 2. Galectin-3 is upregulated in tumor cell emboli in both primary tumors and metastatic lesions of malignant CMT
Fig. 5. Galectin-3 is upregulated in tumor cell emboli from both primary tumors and metastatic lesions of malignant CMT-U27 xenografts
Fig. 6. Galectin-3-binding sites are downregulated in the ECM while expressed in tumor cell emboli in malignant CMT
+7

Referências

Documentos relacionados

das ou de montante variável devem ser iguais ao que tiver sido consignado para o ano em curso, salvo se se explicarem satisfatoriamente os motivos d o seu

Specific genes that are predominantly expressed or exclusively expressed in prostate cells, prostate cancer cells, and prostate metastasis cells at the level of DNA, RNA and

molecule expression and lymphocyte adhesion to endothelial cells: effect of nitric oxide. Exp

Silvers et al., “Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer,” The Prostate , vol.

We compared the proliferation of the human breast cancer cell line MDA-MB-231 and of the non-cancer human mammary epithelial cell line MCF-10A in different experimental

Primary human bone marrow stromal cells (hMSCs) were transfected with human telomerase reverse transcriptase (hTERT) gene with lipofection method.. The hTERT transfected hMSCs

Quantitative gene expression of laminin-332 γ2 in samples of canine mammary cancer (black columns) and in a pool of normal mammary tissues (zero or 0)... A controversial role

Interestingly, androgen receptor acts as a stimulator for prostate cancer proliferation and metastasis in stromal cells, as a survival factor of prostatic cancer